Three-year developmental outcomes in children with prenatal alcohol and drug exposure

Deborah Kartin1, Therese M Grant, Ann P Streissguth

  • 1Department of Rehabilitation Medicine (D.K.), Fetal Alcohol and Drug Unit, Department of Psychiatry and Behavioral Sciences (T.M.G., A.P.S., C.C.E.), School of Medicine, and Department of Statistics (P.D.S.), University of Washington, Seattle, Wash.

Insights

Children prenatally exposed to alcohol and drugs showed lower developmental performance. A home visitation program was insufficient to overcome these risks, suggesting a need for more comprehensive services.

Area of Science:

  • Pediatrics
  • Developmental Psychology
  • Public Health

Background:

  • Prenatal exposure to alcohol and drugs poses significant risks to child development.
  • Assessing developmental outcomes in children with prenatal substance exposure is crucial for early intervention.

Purpose of the Study:

  • To evaluate the developmental performance of children exposed to maternal alcohol and drug abuse during pregnancy.
  • To investigate the impact of prenatal binge alcohol exposure and prematurity on developmental outcomes.
  • To examine the effectiveness of a home visitation intervention program.

Main Methods:

  • Children were recruited from hospital and community settings.
  • Participants were assigned to a home visitation intervention or a control group.
  • Developmental outcomes were assessed using the Bayley Scales of Infant Development Second Edition (BSID-II) at three years.

Main Results:

  • Children exposed prenatally to alcohol and drugs demonstrated, on average, substantially lower developmental scores than expected.
  • Maternal binge drinking was associated with slightly lower Mental Developmental Index (MDI) and Psychomotor Developmental Index (PDI) scores.
  • The home visitation intervention showed no systematic effect on developmental outcomes.

Conclusions:

  • Prenatal alcohol and drug exposure significantly impacts preschool children's development.
  • Standard home visitation programs may not be sufficient to mitigate the complex developmental risks associated with prenatal substance exposure.
  • Further research into comprehensive, multidimensional services tailored for these children is recommended.
Abstract

Related Concept Videos

Three Developmental Domains01:29

Three Developmental Domains

Human development is typically examined across three main domains: physical, cognitive, and socio-emotional. These domains represent the significant areas of change and continuity throughout the lifespan, from infancy to late adulthood.
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.